PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

46,701 stories, page 760 of 779

Advanced search
🇮🇪Industrydeciphex.comTier 1 · Company source

Deciphex Enters into Collaboration Agreement with Novartis to Advance AI in Preclinical Studies

DeciphexOriginal source
🇮🇪Industrydeciphex.comTier 1 · Company source

Deciphex Enables First Digital GLP Peer Review Conducted by a Consultant for a Contract Research Provider

DeciphexOriginal source
🇮🇪Industrydeciphex.comTier 1 · Company source

Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology

DeciphexOriginal source
🇮🇪Industrydeciphex.comTier 1 · Company source

Charles River and Deciphex Extend Global Partnership to Expand Digital Pathology Offering with Exclusive Image Management Solutions

DeciphexOriginal source
🇮🇪Industrydeciphex.comTier 1 · Company source

AI Has Arrived in Pathology

DeciphexOriginal source
🇦🇺Industrycsl.comTier 3 · Secondary coverage

Our Impact | CSL

CSL BehringOriginal source
🇦🇺Industrycsl.comTier 3 · Secondary coverage

Our Businesses and Products

CSL BehringOriginal source
🇦🇺Industrycsl.comTier 3 · Secondary coverage

Frequently Asked Questions | CSL

CSL BehringOriginal source
🇦🇺Industrycsl.comTier 3 · Secondary coverage

Core Policies | CSL

CSL BehringOriginal source
🇦🇺Industrycsl.comTier 3 · Secondary coverage

Code of Conduct | CSL

CSL BehringOriginal source
🇺🇸CDMOcrucialdatasolutions.comTier 2 · Direct publisher

Crucial Data Solutions Sets Another Industry Benchmark: TrialKit Now Available as a Native macOS App - Crucial Data Solutions

TrialKitOriginal source
🇺🇸CDMOcrucialdatasolutions.comTier 2 · Direct publisher

TrialKit AI: Revolutionizing Clinical Research Analytics with AI - Crucial Data Solutions

TrialKitOriginal source
🇺🇸CDMOcrucialdatasolutions.comTier 2 · Direct publisher

Crucial Data Solutions and PetPace Form Strategic Alliance to Bring Real-Time, At-Home Animal Health Monitoring to Clinical Research

TrialKitOriginal source
🇺🇸CDMOcrucialdatasolutions.comTier 2 · Direct publisher

Crucial Data Solutions Launches Industry-First Subscription Model to Modernize Clinical Trial Contracting and Pricing

TrialKitOriginal source
🇺🇸CDMOcrucialdatasolutions.comTier 2 · Direct publisher

Crucial Data Solutions Recognized as a Major Contender in Everest Group’s Decentralized Clinical Trial Platforms PEAK Matrix® Assessment 2023 - Crucial Data Solutions

TrialKitOriginal source
🇺🇸CDMOcrucialdatasolutions.comTier 2 · Direct publisher

Crucial Data Solutions Introduces TrialKit PACS to Streamline Image Management in Clinical Trials - Crucial Data Solutions

TrialKitOriginal source
🇺🇸CDMOcrucialdatasolutions.comTier 2 · Direct publisher

Crucial Data Solutions and nmible Join Forces to Provide a Solution for Seamless Participant Reimbursement in Clinical Trials - Crucial Data Solutions

TrialKitOriginal source
🇺🇸CDMOcrucialdatasolutions.comTier 2 · Direct publisher

Crucial Data Solutions Names Dr. Leigh J. Mack Chief Medical Officer Amid Industry AI Shift - Crucial Data Solutions

TrialKitOriginal source
🇺🇸CDMOcrucialdatasolutions.comTier 2 · Direct publisher

Crucial Data Solutions Unveils Groundbreaking AI-Driven Reporting and Analytics Module with TrialKit AI

TrialKitOriginal source
🇰🇷Devicescorelinesoft.comTier 1 · Company source

코어라인소프트, 美 세인트조셉스에 흉부 CT AI 구축

Coreline SoftOriginal source
🇰🇷Devicescorelinesoft.comTier 1 · Company source

코어라인소프트·옵텔럼, 폐결절 AI 협력 확대

Coreline SoftOriginal source
🇰🇷Devicescorelinesoft.comTier 1 · Company source

코어라인소프트, 美 3DR 사용량 60%↑

Coreline SoftOriginal source
🇰🇷Devicescorelinesoft.comTier 1 · Company source

코어라인소프트, 상반기 최대 매출·해외 매출 123% 성장

Coreline SoftOriginal source
🇰🇷Devicescorelinesoft.comTier 1 · Company source

코어라인소프트, 캐논과 독일 폐암검진 장기 운영 프로젝트

Coreline SoftOriginal source
🇰🇷Devicescorelinesoft.comTier 1 · Company source

흉부 CT AI 검진 리포트 확대

Coreline SoftOriginal source
🇰🇷Devicescorelinesoft.comTier 1 · Company source

코어라인소프트, AVIEW Modeler 교육 현장 확대

Coreline SoftOriginal source
🇰🇷Devicescorelinesoft.comTier 1 · Company source

코어라인소프트 AVIEW CAC, 혁신제품 지정서 수여

Coreline SoftOriginal source
🇪🇸Researchcnio.esTier 2 · Direct publisher

WISE -

CNIO (Spanish Cancer Research)Original source
🇪🇸Researchcnio.esTier 2 · Direct publisher

Videos -

CNIO (Spanish Cancer Research)Original source
🇪🇸Researchcnio.esTier 2 · Direct publisher

Translational -

CNIO (Spanish Cancer Research)Original source
🇪🇸Researchcnio.esTier 2 · Direct publisher

Outreach to Society -

CNIO (Spanish Cancer Research)Original source
🇪🇸Researchcnio.esTier 2 · Direct publisher

Innovation -

CNIO (Spanish Cancer Research)Original source
🇪🇸Researchcnio.esTier 2 · Direct publisher

CNIO Friends Newsletter -

CNIO (Spanish Cancer Research)Original source
🇪🇸Researchcnio.esTier 2 · Direct publisher

CNIO News -

CNIO (Spanish Cancer Research)Original source
🇪🇸Researchcnio.esTier 2 · Direct publisher

CNIO Friends -

CNIO (Spanish Cancer Research)Original source
🇪🇸Researchcnio.esTier 2 · Direct publisher

CNIO Alumni -

CNIO (Spanish Cancer Research)Original source
🇪🇸Researchcnio.esTier 2 · Direct publisher

Basic Research -

CNIO (Spanish Cancer Research)Original source
🌍Researchclevelandclinicabudhabi.aeTier 2 · Direct publisher

Media Center: Latest News & Press Releases

Cleveland Clinic Abu DhabiOriginal source
🇯🇵CDMOchugai-pharm.co.jpTier 2 · Direct publisher

Oct 16,2026 | Chugai Receives Porter Prize 2026 | News | CHUGAI PHARMACEUTICAL CO., LTD.

Chugai PharmaceuticalOriginal source
🇯🇵CDMOchugai-pharm.co.jpTier 2 · Direct publisher

Oct 16,2026 | Roche’s Announcement Regarding Enspryng (FDA Approval for Thyroid Eye Disease) | News | CHUGAI PHARMACEUTICAL CO., LTD.

Chugai PharmaceuticalOriginal source
🇯🇵CDMOchugai-pharm.co.jpTier 2 · Direct publisher

Oct 13,2026 | Roche's Announcement Regarding Vamikibart (1 Year Data in Uveitic Macular Edema) | News | CHUGAI PHARMACEUTICAL CO., LTD.

Chugai PharmaceuticalOriginal source
🇯🇵CDMOchugai-pharm.co.jpTier 2 · Direct publisher

Sep 30,2026 | Establishment of a Subsidiary in South Korea | News | CHUGAI PHARMACEUTICAL CO., LTD.

Chugai PharmaceuticalOriginal source
🇯🇵CDMOchugai-pharm.co.jpTier 2 · Direct publisher

Chugai and InxMed Enter into a Worldwide License Agreement for SPYK04, a RAF-MEK Molecular Glue

Chugai PharmaceuticalOriginal source
🇯🇵CDMOchugai-pharm.co.jpTier 2 · Direct publisher

Sep 28,2026 | Notice Regarding Discontinuation of Development of GYM329 (emugrobart) for Obesity, Return of License and Resumption of Development for SMA | News | CHUGAI PHARMACEUTICAL CO., LTD.

Chugai PharmaceuticalOriginal source
🇯🇵CDMOchugai-pharm.co.jpTier 2 · Direct publisher

Sep 24,2026 | Roche’s Announcement Regarding Sefaxersen (Announcement of Interim Analysis Results from the Phase III IMAGINATION Study) | News | CHUGAI PHARMACEUTICAL CO., LTD.

Chugai PharmaceuticalOriginal source
🇯🇵CDMOchugai-pharm.co.jpTier 2 · Direct publisher

Chugai Obtains Approval for FoundationOne CDx Cancer Genomic Profile as a Companion Diagnostic of Lorlatinib for ALK Fusion Gene-Positive Non-Small Cell Lung Cancer

Chugai PharmaceuticalOriginal source
🇯🇵CDMOchugai-pharm.co.jpTier 2 · Direct publisher

Sep 17,2026 | Roche Announces Phase III CELESTIMO Study Results for Lunsumio in Relapsed or Refractory Follicular Lymphoma | News | CHUGAI PHARMACEUTICAL CO., LTD.

Chugai PharmaceuticalOriginal source
🇯🇵CDMOchugai-pharm.co.jpTier 2 · Direct publisher

Chugai Obtains Approval for FoundationOne CDx Cancer Genomic Profile as a Companion Diagnostic of Tovorafenib for BRAF V600 Alterations and BRAF Fusion Gene-Positive Glioma

Chugai PharmaceuticalOriginal source
🇯🇵CDMOchugai-pharm.co.jpTier 2 · Direct publisher

Roche Announces U.S. FDA Grants Priority Review for Enspryng for Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)

Chugai PharmaceuticalOriginal source
🇯🇵CDMOchugai-pharm.co.jpTier 2 · Direct publisher

Three Chugai Researchers Behind the Discovery of Hemlibra for Hemophilia A Receive Prestigious U.S. Lasker Award, One of the World’s Most Respected Scientific Honors - Recognized for the invention of a bispecific antibody that transformed treatment paradigm through an unconventional approach –

Chugai PharmaceuticalOriginal source
🇯🇵CDMOchugai-pharm.co.jpTier 2 · Direct publisher

Research Achievement Related to Chugai-Originated Nemolizumab Receives the 11th JBDA Award for Drug Discovery

Chugai PharmaceuticalOriginal source
🇯🇵CDMOchugai-pharm.co.jpTier 2 · Direct publisher

Vamikibart Filed for Regulatory Approval in Japan for Uveitic Macular Edema Associated with Non-Infectious Uveitis

Chugai PharmaceuticalOriginal source
🇯🇵CDMOchugai-pharm.co.jpTier 2 · Direct publisher

Chugai and GSK Sign Exclusive License Agreement for Anti-Dengue Virus Antibody AID351

Chugai PharmaceuticalOriginal source
🇯🇵CDMOchugai-pharm.co.jpTier 2 · Direct publisher

Chugai Files for Additional Indication of Tecentriq for Adjuvant Treatment of MSI-High Colon Cancer

Chugai PharmaceuticalOriginal source
🇯🇵CDMOchugai-pharm.co.jpTier 2 · Direct publisher

Chugai and UCSF Establish Master Collaboration Agreement for Drug Discovery Research - A Framework to Streamline Future Research Projects-

Chugai PharmaceuticalOriginal source
🇯🇵CDMOchugai-pharm.co.jpTier 2 · Direct publisher

Aug 03,2026 | Announcement of Partnership with the Japan Basketball Association (JBA) | News | CHUGAI PHARMACEUTICAL CO., LTD.

Chugai PharmaceuticalOriginal source
🇯🇵CDMOchugai-pharm.co.jpTier 2 · Direct publisher

Chugai Files for Additional Indication of Enspryng as Japan’s Potential First Treatment for Prevention of Relapse in MOG Antibody-associated Disease

Chugai PharmaceuticalOriginal source
🇯🇵CDMOchugai-pharm.co.jpTier 2 · Direct publisher

Jul 29,2026 | Support for Areas Affected by the 2026 Kumamoto Prefecture Earthquake | News | CHUGAI PHARMACEUTICAL CO., LTD.

Chugai PharmaceuticalOriginal source
🇩🇪Researchcharite.deTier 2 · Direct publisher

RSS Feed: Charité – Universitätsmedizin Berlin

Charité – Universitätsmedizin BerlinOriginal source
🇩🇪Researchcharite.deTier 2 · Direct publisher

Leichte Sprache: Charité – Universitätsmedizin Berlin

Charité – Universitätsmedizin BerlinOriginal source